171 related articles for article (PubMed ID: 30496479)
1. canSAR: update to the cancer translational research and drug discovery knowledgebase.
Coker EA; Mitsopoulos C; Tym JE; Komianou A; Kannas C; Di Micco P; Villasclaras Fernandez E; Ozer B; Antolin AA; Workman P; Al-Lazikani B
Nucleic Acids Res; 2019 Jan; 47(D1):D917-D922. PubMed ID: 30496479
[TBL] [Abstract][Full Text] [Related]
2. canSAR: update to the cancer translational research and drug discovery knowledgebase.
Mitsopoulos C; Di Micco P; Fernandez EV; Dolciami D; Holt E; Mica IL; Coker EA; Tym JE; Campbell J; Che KH; Ozer B; Kannas C; Antolin AA; Workman P; Al-Lazikani B
Nucleic Acids Res; 2021 Jan; 49(D1):D1074-D1082. PubMed ID: 33219674
[TBL] [Abstract][Full Text] [Related]
3. canSAR: an updated cancer research and drug discovery knowledgebase.
Tym JE; Mitsopoulos C; Coker EA; Razaz P; Schierz AC; Antolin AA; Al-Lazikani B
Nucleic Acids Res; 2016 Jan; 44(D1):D938-43. PubMed ID: 26673713
[TBL] [Abstract][Full Text] [Related]
4. canSAR: update to the cancer translational research and drug discovery knowledgebase.
di Micco P; Antolin AA; Mitsopoulos C; Villasclaras-Fernandez E; Sanfelice D; Dolciami D; Ramagiri P; Mica IL; Tym JE; Gingrich PW; Hu H; Workman P; Al-Lazikani B
Nucleic Acids Res; 2023 Jan; 51(D1):D1212-D1219. PubMed ID: 36624665
[TBL] [Abstract][Full Text] [Related]
5. canSAR: updated cancer research and drug discovery knowledgebase.
Bulusu KC; Tym JE; Coker EA; Schierz AC; Al-Lazikani B
Nucleic Acids Res; 2014 Jan; 42(Database issue):D1040-7. PubMed ID: 24304894
[TBL] [Abstract][Full Text] [Related]
6. canSAR: an integrated cancer public translational research and drug discovery resource.
Halling-Brown MD; Bulusu KC; Patel M; Tym JE; Al-Lazikani B
Nucleic Acids Res; 2012 Jan; 40(Database issue):D947-56. PubMed ID: 22013161
[TBL] [Abstract][Full Text] [Related]
7. ICR expands CanSAR drug discovery platform.
Cancer Discov; 2014 Jan; 4(1):OF3. PubMed ID: 24402955
[TBL] [Abstract][Full Text] [Related]
8. canSAR chemistry registration and standardization pipeline.
Dolciami D; Villasclaras-Fernandez E; Kannas C; Meniconi M; Al-Lazikani B; Antolin AA
J Cheminform; 2022 May; 14(1):28. PubMed ID: 35643512
[TBL] [Abstract][Full Text] [Related]
9. Distinctive Behaviors of Druggable Proteins in Cellular Networks.
Mitsopoulos C; Schierz AC; Workman P; Al-Lazikani B
PLoS Comput Biol; 2015 Dec; 11(12):e1004597. PubMed ID: 26699810
[TBL] [Abstract][Full Text] [Related]
10. The canSAR data hub for drug discovery.
Chau CH; O'Keefe BR; Figg WD
Lancet Oncol; 2016 Mar; 17(3):286. PubMed ID: 26972856
[No Abstract] [Full Text] [Related]
11. Open Targets Platform: supporting systematic drug-target identification and prioritisation.
Ochoa D; Hercules A; Carmona M; Suveges D; Gonzalez-Uriarte A; Malangone C; Miranda A; Fumis L; Carvalho-Silva D; Spitzer M; Baker J; Ferrer J; Raies A; Razuvayevskaya O; Faulconbridge A; Petsalaki E; Mutowo P; Machlitt-Northen S; Peat G; McAuley E; Ong CK; Mountjoy E; Ghoussaini M; Pierleoni A; Papa E; Pignatelli M; Koscielny G; Karim M; Schwartzentruber J; Hulcoop DG; Dunham I; McDonagh EM
Nucleic Acids Res; 2021 Jan; 49(D1):D1302-D1310. PubMed ID: 33196847
[TBL] [Abstract][Full Text] [Related]
12. ECOdrug: a database connecting drugs and conservation of their targets across species.
Verbruggen B; Gunnarsson L; Kristiansson E; Österlund T; Owen SF; Snape JR; Tyler CR
Nucleic Acids Res; 2018 Jan; 46(D1):D930-D936. PubMed ID: 29140522
[TBL] [Abstract][Full Text] [Related]
13. Rethinking 'academic' drug discovery: the Manchester Institute perspective.
Jordan AM; Waddell ID; Ogilvie DJ
Drug Discov Today; 2015 May; 20(5):525-35. PubMed ID: 25542353
[TBL] [Abstract][Full Text] [Related]
14. CDEK: Clinical Drug Experience Knowledgebase.
Griesenauer RH; Schillebeeckx C; Kinch MS
Database (Oxford); 2019 Jan; 2019():. PubMed ID: 31411687
[TBL] [Abstract][Full Text] [Related]
15. DGIdb 3.0: a redesign and expansion of the drug-gene interaction database.
Cotto KC; Wagner AH; Feng YY; Kiwala S; Coffman AC; Spies G; Wollam A; Spies NC; Griffith OL; Griffith M
Nucleic Acids Res; 2018 Jan; 46(D1):D1068-D1073. PubMed ID: 29156001
[TBL] [Abstract][Full Text] [Related]
16. Chemical biology approaches to target validation in cancer.
Blagg J; Workman P
Curr Opin Pharmacol; 2014 Aug; 17():87-100. PubMed ID: 25175311
[TBL] [Abstract][Full Text] [Related]
17. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets.
Guo J; Liu H; Zheng J
Nucleic Acids Res; 2016 Jan; 44(D1):D1011-7. PubMed ID: 26516187
[TBL] [Abstract][Full Text] [Related]
18. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis.
Sherman BT; Huang da W; Tan Q; Guo Y; Bour S; Liu D; Stephens R; Baseler MW; Lane HC; Lempicki RA
BMC Bioinformatics; 2007 Nov; 8():426. PubMed ID: 17980028
[TBL] [Abstract][Full Text] [Related]
19. CTRR-ncRNA: A Knowledgebase for Cancer Therapy Resistance and Recurrence Associated Non-coding RNAs.
Tang T; Liu X; Wu R; Shen L; Ren S; Shen B
Genomics Proteomics Bioinformatics; 2023 Apr; 21(2):292-299. PubMed ID: 36265769
[TBL] [Abstract][Full Text] [Related]
20. CATTLE (CAncer treatment treasury with linked evidence): An integrated knowledge base for personalized oncology research and practice.
Soysal E; Lee HJ; Zhang Y; Huang LC; Chen X; Wei Q; Zheng W; Chang JT; Cohen T; Sun J; Xu H
CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):188-196. PubMed ID: 28296354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
